Autism Spectrum Disorder Diagnostics Global Market Opportunities And Strategies To 2034

The autism spectrum disorder diagnostics market is segmented by type into autistic disorder, asperger syndrome, pervasive developmental disorder (PDD) and other types. The autistic disorder market was the largest segment of the autism spectrum disorder diagnostics market segmented by type, accounting for 52.82% or $14.46 billion of the total in 2024. Going forward, the autistic disorder segment is expected to be the fastest growing segment in the autism spectrum disorder diagnostics market segmented by type, at a CAGR of 5.46% during 2024-2029.

The autism spectrum disorder diagnostics market is segmented by distribution channel into hospital pharmacies, drug stores and retail pharmacies and online pharmacies. The drug stores and retail pharmacies market was the largest segment of the autism spectrum disorder diagnostics market segmented by distribution channel, accounting for 47.38% or $12.97 billion of the total in 2024. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the autism spectrum disorder diagnostics market segmented by distribution channel, at a CAGR of 13.00% during 2024-2029.

The autism spectrum disorder diagnostics market is segmented by service into behavioral approaches, early intervention, medication and other services. The behavioral approaches market was the largest segment of the autism spectrum disorder diagnostics market segmented by service, accounting for 46.21% or $12.65 billion of the total in 2024. Going forward, the early intervention segment is expected to be the fastest growing segment in the autism spectrum disorder diagnostics market segmented by service, at a CAGR of 6.14% during 2024-2029.

North America was the largest region in the autism spectrum disorder diagnostics market, accounting for 42.06% or $11.51 billion of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the autism spectrum disorder diagnostics market will be Asia Pacific and Western Europe where growth will be at CAGRs of 6.01% and 5.16% respectively. These will be followed by Africa and North America where the markets are expected to grow at CAGRs of 4.96% and 4.63% respectively.

The global autism spectrum disorder diagnostics market is fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 6.24% of the total market in 2023. Laboratory Corporation of America Holdings (LabCorp) was the largest competitor with a 2.17% share of the market, followed by Illumina Inc. with 0.95%, Bio-Rad Laboratories Inc. with 0.75% Quest Diagnostics Incorporated with 0.60%, Ambry Genetics Corp. with 0.54%, ARUP Laboratories Inc. with 0.49%, Cortica Inc. with 0.38%, GeneDx Holding Corp. with 0.17%, Centogene N.V. with 0.12% and Caravel Autism Health LLC with 0.07%.

The top opportunities in the autism spectrum disorder diagnostics market segmented by type will arise in the autistic disorder segment, which will gain $4.4 billion of global annual sales by 2029. The top opportunities in the autism spectrum disorder diagnostics market segmented by service will arise in the behavioral approaches segment, which will gain $3.62 billion of global annual sales by 2029. The top opportunities in the autism spectrum disorder diagnostics market segmented by distribution channel will arise in the online pharmacies segment, which will gain $5.0 billion of global annual sales by 2029. The autism spectrum disorder diagnostics market size will gain the most in the USA at $2.62 billion.

Market-trend-based strategies for the autism spectrum disorder diagnostics market include focus on launch of innovative diagnostic aid for autism spectrum disorder (ASD), focus on innovative technologies and tools enhance early detection and diagnosis, focus on strategic partnerships and collaborations, focus on launch of ai solutions to transform autism care and advance health equity and focus on development of innovative autism drug trial tracker to streamline clinical trials.

This report describes and explains the autism spectrum disorder diagnostics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global autism spectrum disorder diagnostics market reached a value of nearly $27.38 billion in 2024, having grown at a compound annual growth rate (CAGR) of 3.46% since 2019. The market is expected to grow from $27.38 billion in 2024 to $35.05 billion in 2029 at a rate of 5.06%. The market is then expected to grow at a CAGR of 4.35% from 2029 and reach $43.36 billion in 2034.

Growth in the historic period resulted from the increasing parental awareness, rising demand for personalized treatment and growth in specialized diagnostic centers. Factors that negatively affected growth in the historic period was limited clinical trial participation and high treatment costs.

Going forward, growing healthcare expenditure, rising investments in research and development, government initiatives and funding and increasing prevalence of autism spectrum disorders (ASD) will drive the growth. Factor that could hinder the growth of the autism spectrum disorder diagnostics market in the future include lack of healthcare infrastructure and inherent complexity and variability of ASD.

Player-adopted strategies in the autism spectrum disorder diagnostics market include focuses on expanding its business capabilities through partnership.

To take advantage of the opportunities, the analyst recommends the autism spectrum disorder diagnostics market companies to focus on advanced diagnostic tools to improve accuracy and early intervention, focus on AI-driven early diagnosis tools to improve accuracy and speed, focus on AI-driven digital phenotyping to expand access and personalize care, focus on AI-powered trial monitoring tools to accelerate treatment development, focus on autistic disorder to capitalize on the largest and fastest-growing segment, focus on early intervention to capture the fastest-growing treatment opportunity, expand in emerging markets, focus on strategic collaborations and acquisitions to strengthen diagnostic capabilities, focus on tiered pricing to expand access and maximize revenue across user segments, focus on evidence-based awareness campaigns to strengthen market trust, focus on digital platforms to broaden reach and personalize engagement, focus on online pharmacies to leverage the fastest-growing distribution channel.

This product will be delivered within 3-5 business days.